Andrew Brunner, MD

Andrew Brunner, MD, is from the Massachusetts General Hospital at Harvard Medical School.

Articles by Andrew Brunner, MD

Thomas LeBlanc, MD, MAMyelodysplastic Syndromes | February 18, 2025
Drs. Thomas LeBlanc, Jamie Koprivnikar, and Andrew Brunner give their predictions for the future of MDS management.
Jamie Koprivnikar, MDMyelodysplastic Syndromes | February 18, 2025
An expert panel delves into new data regarding the long-term efficacy of luspatercept in MDS.
Jamie Koprivnikar, MDMyelodysplastic Syndromes | February 18, 2025
An expert MDS panel discusses patient reported outcomes, transfusion dependence, and time toxicity.
Thomas LeBlanc, MD, MAMyelodysplastic Syndromes | January 10, 2025
Discussing the COMMANDS trial and sequencing luspatercept in patients with myelodysplastic syndromes.
Thomas LeBlanc, MD, MAMyelodysplastic Syndromes | January 31, 2025
How to address ESA failure or ineligibility in patients with MDS...
Thomas LeBlanc, MD, MAMyelodysplastic Syndromes | January 27, 2025
Results from a real-world analysis of post-ESA treatment outcomes in patients with lower-risk myelodysplastic syndrome.
Hana Safah, MDVideo Insights | January 24, 2024
The panel shares their outlook for the future of MDS research and treatment.
Hana Safah, MDVideo Insights | December 19, 2023
Dr. Tanaka outlines a biomarker study that observed reduced inflammation in patients with MDS treated with luspatercept.
Hana Safah, MDVideo Insights | December 19, 2023
The panel discussed a study that assessed quality of life and PROs in patients receiving luspatercept for MDS.
Hana Safah, MDVideo Insights | December 19, 2023
The panel discusses whether starting treatment with luspatercept sooner in patients with MDS is beneficial.
Hana Safah, MDVideo Insights | February 8, 2024
Dr. Shammo shares her reaction to a study that assessed mutational burden and impact on primary outcomes in COMMANDS.
Hana Safah, MDVideo Insights | December 19, 2023
Dr. Safah outlines the findings from the full analysis of the COMMANDS trial.
Hana Safah, MDVideo Insights | December 19, 2023
The panel discusses the evolution of MDS therapy.
Hana Safah, MDVideo Insights | January 12, 2024
Dr. Safah gave an overview of myelodysplastic syndromes.